GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Novadaq Technologies Inc. (NVDQ) [hlAlert]

Rating:
Outperform
NVDQ
down 33.82 %

Novadaq Technologies Inc. (NVDQ) rated Outperform by William Blair

Posted on: Friday,  Nov 15, 2013  1:25 PM ET by William Blair

William Blair rated Outperform Novadaq Technologies Inc. (NASDAQ: NVDQ) on 11/15/2013, when the stock price was $17.00. Since
then, Novadaq Technologies Inc. has lost 33.82% as of 01/06/2016's recent price of $11.25.
If you would have followed this William Blair's recommendation on NVDQ, you would have lost 33.82% of your investment in 782 days.

Novadaq Technologies Inc. (Novadaq) develops and commercializes medical imaging and therapeutic devices for use in the operating room. The Company?s imaging platform can be used to visualize blood vessels, nerves and the lymphatic system during surgical procedures. Novadaq develops and markets real-time fluorescence imaging technologies for use in the operating room. The company?s key markets include plastic reconstructive, gastrointestinal, cardiac and general surgery. The Company?s primary core technology platform, SPY Imaging provides anatomic and physiologic images during a variety of complex open and minimally invasive surgical (MIS) procedures. In January 2009, Novadaq announced its first alliance with Intuitive Surgical, Inc., to integrate SPY imaging into the da Vinci Surgical Robot.

The Equity Research department provides the firm's clients with in-depth investment analysis and investment recommendations. Acting as the company's laboratory for new investment ideas, it specializes in providing investment analysis on quality growth companies. Located together in our Chicago office, our equity analysts currently follow a universe of nearly 360 companies.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/15/2013 1:25 PM Buy
None
17.00
as of 12/13/2013
1 Week down  -1.35 %
1 Month down  -5.52 %
3 Months   
1 YTD down  -5.52 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy